REMTERNETUG
UNII A5HTA4J6ME

Substance Identification & Data

This profile provides standardized clinical and technical data for Remternetug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A5HTA4J6ME.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2571940-41-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A5HTA4J6ME

CAS Registry Number

2571940-41-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REMTERNETUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190754

National Cancer Institute reference terminology for clinical and research data.

INN ID

12364

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-220

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Remternetug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REMTERNETUG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (DE-452-LYSINE), ANTI-(HUMAN (3-PYROGLUTAMYL) .BETA.-AMYLOID) (HUMAN MONOCLONAL LY3372993 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3372993 .KAPPA.-CHAIN, DIMER

REMTERNETUG [INN]

REMTERNETUG [USAN]